XTANT Medical Holdings, Inc recalls nanOss 3D Advanced Bone Graft Substitute nanOss 3D Plus Advanced Bone Graft Substitute 90-300-251008: nanOss 3D Advance…
- Recall date
- March 9, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1897-2026
- FDA classification
- Class II
- Brand / firm
- XTANT Medical Holdings, Inc
- Sold / distributed
- US Nationwide distribution in the states and territories of CA, CT, DC, KS, MD, NC, NY, TX, and WI.
Why it was recalled
Products were incorrectly labeled with a 5-year shelf life. The approved and validated shelf life is four years.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
nanOss 3D Advanced Bone Graft Substitute nanOss 3D Plus Advanced Bone Graft Substitute 90-300-251008: nanOss 3D Advanced Bone Graft Substitute, 25x100x8mm, 20cc 90-300-25508: nanOss 3D Advanced Bone Graft Substitute, 25x50x8mm, 10cc 90-300-251004: nanOss 3D Advanced Bone Graft Substitute, 25x100x4mm, 10cc 90-400-25508: nanOss 3D Plus Advanced Bone Graft Substitute, 25x50x8mm, 10cc
Get recall alerts
Free email alert whenever XTANT Medical Holdings, Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: XTANT Medical Holdings, Inc